SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-042135
Filing Date
2023-02-21
Accepted
2023-02-17 17:41:13
Documents
17
Period of Report
2023-02-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d449156d8k.htm   iXBRL 8-K 26552
2 EX-99.1 d449156dex991.htm EX-99.1 39903
6 GRAPHIC g449156g0217234017158.jpg GRAPHIC 1703
7 GRAPHIC g449156g0217234017345.jpg GRAPHIC 1741
8 GRAPHIC g449156g0217234017845.jpg GRAPHIC 1477
9 GRAPHIC g449156g0217235118041.jpg GRAPHIC 2495
  Complete submission text file 0001193125-23-042135.txt   210837

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amrn-20230217.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20230217_lab.xml EX-101.LAB 18689
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20230217_pre.xml EX-101.PRE 11692
11 EXTRACTED XBRL INSTANCE DOCUMENT d449156d8k_htm.xml XML 3692
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 23644264
SIC: 2834 Pharmaceutical Preparations